Related Experiment Videos
Alexander disease: a leukodystrophy caused by a mutation in GFAP
1Departments of Pathology and of Neuroscience-K604, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, New York 10461, USA. abminkoff@att.net
Neurochemical Research
|May 14, 2004
Summary
Alexander disease is a rare, fatal neurological disorder. Recent research reveals most cases stem from spontaneous mutations in the glial fibrillary acidic protein (GFAP) gene, not inherited ones.
Area of Science:
- Neuroscience
- Genetics
- Rare Diseases
Background:
- Alexander disease is a rare, fatal central nervous system disorder.
- It leads to progressive motor and mental function loss.
- Previously, its etiology was largely unknown, with most cases being sporadic and untreatable.
Purpose of the Study:
- To investigate the genetic underpinnings of Alexander disease.
- To identify the cause of sporadic and familial cases.
- To understand the mutation patterns associated with different forms of the disease.
Main Methods:
- Genetic analysis of affected individuals and their families.
- Mutation screening of the glial fibrillary acidic protein (GFAP) gene.
- Comparison of mutation types across infantile, juvenile, and adult-onset forms.
Main Results:
- Overwhelmingly, Alexander disease cases exhibit a dominant mutation in one allele of the GFAP gene.
- This mutation results in an amino acid substitution.
- In rare adult-onset cases, the mutation may be inherited; however, most mutations arise spontaneously, likely in parental germ cells.
Conclusions:
- The GFAP gene mutation is the primary cause of most Alexander disease cases.
- Spontaneous mutations are the predominant origin, rather than inheritance.
- Understanding the genetic basis opens avenues for future research into potential treatments.